CRVSCorvus Pharmaceuticals, Inc.
14.46USD-6.10%Mkt Cap: 1.22B $P/E: —3d ago
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the Un…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.22B $
Enterprise Value990.95M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-15.28M $
Revenue/Share—
Last Price14.46 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees37
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS2210151005
Valuation
P/E (Trailing)—
P/E (Forward)-13.42
PEG—
EV/EBITDA-17.43
EV/Revenue—
P/S—
P/B5.35
EPS (TTM)-0.60
EPS (Forward)-1.07
52W Range
5.03043% of range26.95
52W High26.95 USD
52W Low5.030 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-24.97%
ROA-21.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-32.80M $
CapEx (TTM)174.00K $
FCF Margin—
FCF Yield-2.25%
Net Debt-214.50M $
Net Debt/EBITDA3.77
Balance Sheet
Debt/Equity0.02
Current Ratio16.16
Quick Ratio15.88
Book Value/Sh2.679 USD
Cash/Share2.559 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.14 USD
Upside (mean)+129.2%
Target Range27.00 USD – 42.00 USD
$27.00+129.2% to mean$42.00
# Analysts7
Ownership
Shares Out.84.12M
Float72.79M
Insiders3.51%
Institutions86.09%
Short Interest
Short Ratio16.2d
Short % Float24.74%
Short % Out.21.77%
Shares Short18.31M
Short (prev mo.)18.82M
Technical
SMA 5013.92 (+3.9%)
SMA 20013.45 (+7.5%)
Beta0.87
S&P 52W Chg18.16%
Avg Vol (30d)860.71K
Avg Vol (10d)872.99K
Technical Indicators
RSI (14)52.4
MACD0.2990
MACD Signal0.1944
MACD Hist.+0.1045
BB Upper15.58 USD
BB Middle13.99 USD
BB Lower12.40 USD
BB Width22.69%
ATR (14)0.7545 USD
Vol Ratio (20d)0.57x